AbbVie Market Capitalization from 2010 to 2024
ABBV Stock  USD 194.29 1.16 0.59% 
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.19. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
AbbVie  Market Capitalization 
Latest AbbVie's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of AbbVie Inc over the last few years. It is AbbVie's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
View  Last Reported 345.23 B  10 Years Trend 

Market Cap 
Timeline 
AbbVie Market Capitalization Regression Statistics
Arithmetic Mean  110,993,503,333  
Geometric Mean  104,908,476,117  
Coefficient Of Variation  29.75  
Mean Deviation  27,781,843,911  
Median  131,127,740,000  
Standard Deviation  33,016,150,512  
Sample Variance  1090066194.7T  
Range  77.3B  
RValue  0.44  
Mean Square Error  945387625.6T  
RSquared  0.19  
Significance  0.1  
Slope  3,257,347,514  
Total Sum of Squares  15260926725.3T 
AbbVie Market Capitalization History
About AbbVie Financial Statements
AbbVie investors use historical fundamental indicators, such as AbbVie's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding overtime patterns can help investors decide on longterm investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.